Literature DB >> 11588003

Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis.

P J Foley1, D S McGrath, E Puscinska, M Petrek, V Kolek, J Drabek, P A Lympany, P Pantelidis, K I Welsh, J Zielinski, R M du Bois.   

Abstract

Genetic factors, in particular human leukocyte antigens (HLAs) are important determinants of susceptibility to sarcoidosis, a chronic granulomatous disease of undetermined etiology. To clarify the role of HLA in sarcoidosis we determined HLA-DR and -DQ alleles in case-control samples from three European populations (United Kingdom, Czech, and Polish) and compared these results with those published for three additional populations (Italian, Japanese, and Scandinavian) to determine whether the HLA-DR and/or -DQ alleles act as ethnic-dependent, or ethnic-independent modifiers of disease risk. Although variations were apparent in the alleles associated with susceptibility, reductions in the frequency of alleles associated with protection were remarkably consistent in the six populations. Previously detected associations between single-nucleotide polymorphisms at the TAP2 locus and sarcoidosis were shown to be due to linkage disequilibrium with the HLA-DR locus. The protective HLA-DR alleles, which encode the DR1 and DR4 antigens, were found to share characteristic small hydrophobic residues at position 11, which were replaced by small hydrophilic residues in the remaining, nonprotective, HLA-DR alleles. This residue position is within a pocket of the HLA-DR complex antigen binding groove (designated P6), where it is the only variable amino acid and therefore determines the peptide binding preferences of this pocket. A highly significant reduction in the frequency of individuals carrying HLA-DR alleles with a hydrophobic residue at position 11 was observed in the sarcoidosis cases in the three populations we examined. This suggests this HLA-DR residue is an important protective marker in sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588003     DOI: 10.1165/ajrcmb.25.3.4261

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  21 in total

Review 1.  Genetic predisposition to respiratory diseases: infiltrative lung diseases.

Authors:  Mark P Steele; Kevin K Brown
Journal:  Respiration       Date:  2007       Impact factor: 3.580

2.  Early prediction of sarcoidosis prognosis with HLA typing: a 5 year follow-up study.

Authors:  Ezgi Ozyilmaz; Ozlem Goruroglu Ozturk; Ali Durmaz; Orhan Othman Hasan; Bugra Guzelbaba; Gulsah Seydaoglu; Sedat Kuleci; Ismail Hanta; Eren Erken; Ali Kocabas
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients.

Authors:  Johan Grunewald; Boel Brynedal; Pernilla Darlington; Magnus Nisell; Kerstin Cederlund; Jan Hillert; Anders Eklund
Journal:  Respir Res       Date:  2010-02-26

4.  Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

Authors:  Hiroe Sato; Felix A Woodhead; Tariq Ahmad; Jan C Grutters; Paolo Spagnolo; Jules M M van den Bosch; Lisa A Maier; Lee S Newman; Sonoko Nagai; Takateru Izumi; Athol U Wells; Roland M du Bois; Kenneth I Welsh
Journal:  Hum Mol Genet       Date:  2010-08-03       Impact factor: 6.150

Review 5.  Interrogating the major histocompatibility complex with high-throughput genomics.

Authors:  Paul I W de Bakker; Soumya Raychaudhuri
Journal:  Hum Mol Genet       Date:  2012-09-12       Impact factor: 6.150

6.  [Genetic risk profile of sarcoidosis].

Authors:  A Fischer; G Zissel; A Nebel; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

7.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

Authors:  Milton D Rossman; Bruce Thompson; Margaret Frederick; Mary Maliarik; Michael C Iannuzzi; Benjamin A Rybicki; Janardan P Pandey; Lee S Newman; Eleni Magira; Bojana Beznik-Cizman; Dimitri Monos
Journal:  Am J Hum Genet       Date:  2003-08-20       Impact factor: 11.025

Review 8.  Clinical and immunologic components of sarcoidosis.

Authors:  Andrea T Borchers; Calvin So; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

Review 9.  Genetic, Immunologic, and Environmental Basis of Sarcoidosis.

Authors:  David R Moller; Ben A Rybicki; Nabeel Y Hamzeh; Courtney G Montgomery; Edward S Chen; Wonder Drake; Andrew P Fontenot
Journal:  Ann Am Thorac Soc       Date:  2017-12

10.  Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan.

Authors:  Yuri Asukata; Masao Ota; Akira Meguro; Yoshihiko Katsuyama; Mami Ishihara; Kenichi Namba; Nobuyoshi Kitaichi; Shin-Ichiro Morimoto; Toshikatsu Kaburaki; Yasutaka Ando; Shinobu Takenaka; Hidetoshi Inoko; Shigeaki Ohno; Nobuhisa Mizuki
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.